Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 70

1.

Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma.

de Sousa GR, Ribeiro TC, Faria AM, Mariani BM, Lerario AM, Zerbini MC, Soares IC, Wakamatsu A, Alves VA, Mendonca BB, Fragoso MC, Latronico AC, Almeida MQ.

Oncotarget. 2015 Jun 11. [Epub ahead of print]

2.

Development of adrenal cortex zonation.

Xing Y, Lerario AM, Rainey W, Hammer GD.

Endocrinol Metab Clin North Am. 2015 Jun;44(2):243-74. doi: 10.1016/j.ecl.2015.02.001. Review.

PMID:
26038200
3.

Radiographic Characteristics of Adrenal Masses Preceding the Diagnosis of Adrenocortical Cancer.

Nogueira TM, Lirov R, Caoili EM, Lerario AM, Miller BS, Fragoso MC, Dunnick NR, Hammer GD, Else T.

Horm Cancer. 2015 Aug;6(4):176-81. doi: 10.1007/s12672-015-0225-2. Epub 2015 May 29.

PMID:
26021762
4.

DAX1 Overexpression in Pediatric Adrenocortical Tumors: A Synergic Role with SF1 in Tumorigenesis.

de Sousa GR, Soares IC, Faria AM, Domingues VB, Wakamatsu A, Lerario AM, Alves VA, Zerbini MC, Mendonca BB, Fragoso MC, Latronico AC, Almeida MQ.

Horm Metab Res. 2015 May 18. [Epub ahead of print]

PMID:
25985323
5.

Genetics of primary macronodular adrenal hyperplasia.

Fragoso MC, Alencar GA, Lerario AM, Bourdeau I, Almeida MQ, Mendonca BB, Lacroix A.

J Endocrinol. 2015 Jan;224(1):R31-43. doi: 10.1530/JOE-14-0568. Review.

6.

Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer.

Faria AM, Sbiera S, Ribeiro TC, Soares IC, Mariani BM, Freire DS, de Sousa GR, Lerario AM, Ronchi CL, Deutschbein T, Wakamatsu A, Alves VA, Zerbini MC, Mendonca BB, Fragoso MC, Latronico AC, Fassnacht M, Almeida MQ.

Clin Endocrinol (Oxf). 2015 Apr;82(4):481-8. doi: 10.1111/cen.12607. Epub 2014 Nov 3.

PMID:
25200669
7.

Increased expression of ACTH (MC2R) and androgen (AR) receptors in giant bilateral myelolipomas from patients with congenital adrenal hyperplasia.

Almeida MQ, Kaupert LC, Brito LP, Lerario AM, Mariani BM, Ribeiro M, Monte O, Denes FT, Mendonca BB, Bachega TA.

BMC Endocr Disord. 2014 May 12;14:42. doi: 10.1186/1472-6823-14-42.

8.

The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trial.

Lerario AM, Worden FP, Ramm CA, Hesseltine EA, Stadler WM, Else T, Shah MH, Agamah E, Rao K, Hammer GD.

Horm Cancer. 2014 Aug;5(4):232-9. doi: 10.1007/s12672-014-0182-1. Epub 2014 May 22. Erratum in: Horm Cancer. 2014 Dec;5(6):424. Hasseltine, Elizabeth A [corrected to Hesseltine, Elizabeth A].

9.

ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia.

Alencar GA, Lerario AM, Nishi MY, Mariani BM, Almeida MQ, Tremblay J, Hamet P, Bourdeau I, Zerbini MC, Pereira MA, Gomes GC, Rocha Mde S, Chambo JL, Lacroix A, Mendonca BB, Fragoso MC.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1501-9. doi: 10.1210/jc.2013-4237. Epub 2014 Apr 7.

PMID:
24708098
10.

Complete resolution of hypercortisolism with sorafenib in a patient with advanced medullary thyroid carcinoma and ectopic ACTH (adrenocorticotropic hormone) syndrome.

Barroso-Sousa R, Lerario AM, Evangelista J, Papadia C, Lourenço DM Jr, Lin CS, Kulcsar MA, Fragoso MC, Hoff AO.

Thyroid. 2014 Jun;24(6):1062-6. doi: 10.1089/thy.2013.0571. Epub 2014 Mar 21.

PMID:
24499195
11.

Genetics and epigenetics of adrenocortical tumors.

Lerario AM, Moraitis A, Hammer GD.

Mol Cell Endocrinol. 2014 Apr 5;386(1-2):67-84. doi: 10.1016/j.mce.2013.10.028. Epub 2013 Nov 9. Review.

12.

Charles Bonnet syndrome: two case reports and review of the literature.

Lerario A, Ciammola A, Poletti B, Girotti F, Silani V.

J Neurol. 2013 Apr;260(4):1180-6. doi: 10.1007/s00415-013-6857-7. Epub 2013 Feb 5. Review.

PMID:
23381616
13.

POD-1 binding to the E-box sequence inhibits SF-1 and StAR expression in human adrenocortical tumor cells.

França MM, Ferraz-de-Souza B, Santos MG, Lerario AM, Fragoso MC, Latronico AC, Kuick RD, Hammer GD, Lotfi CF.

Mol Cell Endocrinol. 2013 May 22;371(1-2):140-7. doi: 10.1016/j.mce.2012.12.029. Epub 2013 Jan 9.

PMID:
23313103
14.

Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures.

Lerario A, Bonfiglio S, Sormani M, Tettamanti A, Marktel S, Napolitano S, Previtali S, Scarlato M, Natali-Sora M, Mercuri E, Bresolin N, Mongini T, Comi G, Gatti R, Ciceri F, Cossu G, Torrente Y.

BMC Neurol. 2012 Sep 13;12:91. doi: 10.1186/1471-2377-12-91.

15.

Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin.

Heaton JH, Wood MA, Kim AC, Lima LO, Barlaskar FM, Almeida MQ, Fragoso MC, Kuick R, Lerario AM, Simon DP, Soares IC, Starnes E, Thomas DG, Latronico AC, Giordano TJ, Hammer GD.

Am J Pathol. 2012 Sep;181(3):1017-33. doi: 10.1016/j.ajpath.2012.05.026. Epub 2012 Jul 15.

16.

Removal from the plasma of the free and esterified forms of cholesterol and transfer of lipids to HDL in type 2 diabetes mellitus patients.

Oliveira CP, Maranhão RC, Bertato MP, Wajchenberg BL, Lerario AC.

Lipids Health Dis. 2012 Jun 7;11:65. doi: 10.1186/1476-511X-11-65.

17.

Advanced prostate cancer as a cause of oncogenic osteomalacia: an underdiagnosed condition.

Mak MP, da Costa e Silva VT, Martin RM, Lerario AM, Yu L, Hoff PM, de Castro G Jr.

Support Care Cancer. 2012 Sep;20(9):2195-7. doi: 10.1007/s00520-012-1474-z. Epub 2012 May 4.

PMID:
22552356
18.

Plasma kinetics of an LDL-like nanoemulsion and lipid transfer to HDL in subjects with glucose intolerance.

Bertato MP, Oliveira CP, Wajchenberg BL, Lerario AC, Maranhão RC.

Clinics (Sao Paulo). 2012;67(4):347-53.

19.

Glycemic improvement normalizes myocardial microvascular reserve in type 2 diabetes.

Morais NV, Tsutsui JM, Oliveira CP, Uchida AH, Oliveira SF, Lerário AC, Sbano JC, Ramires JA, Porter TR, Mathias W Jr.

Int J Cardiol. 2012 Apr 19;156(2):245-7. doi: 10.1016/j.ijcard.2012.01.046. Epub 2012 Feb 25. No abstract available.

PMID:
22365314
20.

The role of fibroblast growth factor receptor 4 overexpression and gene amplification as prognostic markers in pediatric and adult adrenocortical tumors.

Brito LP, Ribeiro TC, Almeida MQ, Jorge AA, Soares IC, Latronico AC, Mendonca BB, Fragoso MC, Lerario AM.

Endocr Relat Cancer. 2012 May 3;19(3):L11-3. doi: 10.1530/ERC-11-0231. Print 2012 Jun. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk